Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cyclophosphamide
Central Nervous System Neoplasm
UNICANCERP3BB (66)
Cyclophosphamide
Head And Neck Cancer
Zelluna Immunotherapy ASP3BB (66)
Cyclophosphamide
Kidney Cancer
Oliver JonasP3BB (66)
Cyclophosphamide
Lung Cancer
City of Hope Medical CenterP3BB (66)
Cyclophosphamide
Myeloid Neoplasm
Prelude TherapeuticsP3BB (66)
Cyclophosphamide
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Nathan DenlingerP3BB (66)
Cyclophosphamide
Myelodysplastic Syndrome With Single Lineage Dysplasia
Fred Hutchinson Cancer CenterP3BB (66)
Cyclophosphamide
Renal Cell Carcinoma
City of Hope Medical CenterP3BB (66)
Cyclosporin A
Acute Lymphoblastic Leukemia
City of Hope Medical CenterP3BB (66)
Cytarabine
HIV Infectious Disease
AIDS Malignancy ConsortiumP3BB (66)
Cytarabine
Myeloid Leukemia
M.D. Anderson Cancer CenterP3BB (66)
Cytarabine
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P3BB (66)
da-302168s
Obesity Disorder
Chendu DIAO Pharmaceutical Group CO., LTD.P3BB (66)
Daunomycin
Acute Undifferentiated Leukemia
Syndax PharmaceuticalsP3BB (66)
Decitabine
Acute Myeloid Leukemia With 11q23 Abnormalities
Sumithira VasuP3BB (66)
Defactinib
Ovarian Serous Adenocarcinoma
Verastem, Inc.P3BB (66)
Denosumab
Breast Carcinoma
Washington University School of MedicineP3BB (66)
Deucrictibant
Hereditary Angioedema Type 3
Pharvaris Netherlands B.V.P3BB (66)
Dexasone
Metastatic Malignant Neoplasm
GenmabP3BB (66)
Dexasone
Follicular Lymphoma
GenmabP3BB (66)
Dexasone
Marginal Zone Lymphoma
Izidore Lossos, MDP3BB (66)
Dexasone
Myelodysplastic Syndrome With Excess Blasts
National Cancer Institute (NCI)P3BB (66)
Dexasone
Smoldering Plasma Cell Myeloma
Regeneron PharmaceuticalsP3BB (66)
Dexasone
Neoplasm
Hellenic Society of HematologyP3BB (66)
Dexmedetomidine
Bipolar I Disorder
BioXcel Therapeutics IncP3BB (66)
Showing 2176 to 2200 of 42,301 assets
PreviousPage 88 of 1693Next